Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H32N2O5 |
| Molecular Weight | 368.4678 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(O)=O)C(=O)OCC
InChI
InChIKey=IPVQLZZIHOAWMC-OTJKEOIZSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13+,14+,15-,16-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(1''R,3AR)-1'',3A-di-epi-Perindopril is an epimer (S, RS, SR) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This form of the drug is much less active than the parent compound, perindopril.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9533936
Created by
admin on Mon Mar 31 23:24:02 GMT 2025 , Edited by admin on Mon Mar 31 23:24:02 GMT 2025
|
PRIMARY | |||
|
145513-94-6
Created by
admin on Mon Mar 31 23:24:02 GMT 2025 , Edited by admin on Mon Mar 31 23:24:02 GMT 2025
|
PRIMARY | |||
|
J3VG2W26WZ
Created by
admin on Mon Mar 31 23:24:02 GMT 2025 , Edited by admin on Mon Mar 31 23:24:02 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD